[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 11,648
Sort by:

Hemolytic Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hemolytic anemia markets are expected to exhibit a CAGR of 4.15% during 2024-2034. The hemolytic anemia market has been comprehensively analyzed in IMARC's new report titled 'Hemolytic Ane...

May 2024 140 pages

Hemolytic-Uremic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hemolytic-uremic syndrome markets are expected to exhibit a CAGR of 4.7% during 2024-2034. The hemolytic-uremic syndrome market has been comprehensively analyzed in IMARC's new report titl...

May 2024 128 pages

Hemophilia A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hemophilia A markets reached a value of US$ 10,288.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 28,447.2 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

Hemophilia B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hemophilia B markets reached a value of US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.54% du...

May 2024 137 pages

Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The hemorrhoids market has been comprehensively analyzed in IMARC's new report titled 'Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034'. Hem...

May 2024 137 pages

Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The hepatic cirrhosis market has been comprehensively analyzed in IMARC's new report titled 'Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 202...

May 2024 137 pages

Hepatic Encephalopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hepatic encephalopathy markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

Hepatic Insufficiency/Liver Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

 US$ 6,499.00

The 7 major hepatic insufficiency/liver failure markets are expected to exhibit a CAGR of 3.79% during 2024-2034. The hepatic insufficiency/liver failure market has been comprehensively analyzed in IM...

May 2024 133 pages

Hepatitis A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The hepatitis A market reached a value of US$ 588.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 760.2 Million...

May 2024 135 pages

Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The hepatitis B market reached a value of US$ 3.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 4.9 Billion by...

May 2024 134 pages

Hepatitis C Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hepatitis c markets reached a value of US$ 18.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 47.1 Billion by 2034, exhibiting a growth rate (CAGR) of 9.14% du...

May 2024 133 pages

Hepatitis D Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hepatitis D markets reached a value of US$ 665.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 845.3 Million by 2034, exhibiting a growth rate (CAGR) of 2.2% d...

May 2024 134 pages

Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hepatocellular carcinoma markets reached a value of US$ 780 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,520 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 138 pages

Hereditary Central Nervous System Demyelinating Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hereditary central nervous system demyelinating diseases markets are expected to exhibit a CAGR of 9.65% during 2024-2034. The hereditary central nervous system demyelinating diseases mark...

May 2024 139 pages

Hereditary Optic Atrophies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hereditary optic atrophies markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The hereditary optic atrophies market has been comprehensively analyzed in IMARC's new report t...

May 2024 129 pages

Hernia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hernia markets are expected to exhibit a CAGR of 2.28% during 2024-2034. The hernia market has been comprehensively analyzed in IMARC's new report titled 'Hernia Market: Epidemiology, Indu...

May 2024 128 pages

Herpes Zoster Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major herpes zoster markets are expected to exhibit a CAGR of 2.61% during 2024-2034. The herpes zoster market has been comprehensively analyzed in IMARC's new report titled 'Herpes Zoster Marke...

May 2024 133 pages

Heterozygous Familial Hypercholesterolemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major heterozygous familial hypercholesterolemia markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 32.9 Billion by 2034, exhibiting a...

May 2024 140 pages

Hidradenitis Suppurativa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hidradenitis suppurativa markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 136 pages

High-Grade Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major high-grade glioma markets are expected to exhibit a CAGR of 3.45% during 2024-2034. The high-grade glioma market has been comprehensively analyzed in IMARC's new report titled 'High-Grade...

May 2024 130 pages

Hodgkin’s Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Hodgkin’s lymphoma markets reached a value of US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.9 Billion by 2034, exhibiting a growth rate (CAGR) of 10...

May 2024 135 pages

Homocystinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major homocystinuria markets are expected to exhibit a CAGR of 3% during 2024-2034. The homocystinuria market has been comprehensively analyzed in IMARC's new report titled 'Homocystinuria Marke...

May 2024 135 pages

Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major human immunodeficiency virus type 1 markets reached a value of US$ 24.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 39.8 Billion by 2034, exhibiting a growth...

May 2024 134 pages

Human Papillomavirus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major human papillomavirus markets are expected to exhibit a CAGR of 8.33% during 2024-2034. The human papillomavirus market has been comprehensively analyzed in IMARC's new report titled 'Human...

May 2024 133 pages

Hunter Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Hunter syndrome markets reached a value of US$ 702.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,152.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Hutchinson-Gilford Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Hutchinson-Gilford syndrome markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The Hutchinson-Gilford Syndrome market has been comprehensively analyzed in IMARC's new report...

May 2024 133 pages

Hypereosinophilic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypereosinophilic syndrome markets are expected to exhibit a CAGR of 9.32% during 2024-2034. The hypereosinophilic syndrome market has been comprehensively analyzed in IMARC's new report t...

May 2024 139 pages

Hypergammaglobulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypergammaglobulinemia markets are expected to exhibit a CAGR of 7.17% during 2024-2034. The hypergammaglobulinemia market has been comprehensively analyzed in IMARC's new report titled 'H...

May 2024 128 pages

Hyperhidrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperhidrosis markets reached a value of US$ 426.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 651.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.92...

May 2024 133 pages

Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperinsulinemia markets reached a value of US$ 70.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 114.9 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 128 pages

Hyperkalemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperkalemia markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.47% dur...

May 2024 140 pages

Hyperlipoproteinemia Type II Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperlipoproteinemia type II markets are expected to exhibit a CAGR of 6.79% during 2024-2034. The hyperlipoproteinemia type II market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Hyperparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperparathyroidism markets are expected to exhibit a CAGR of 5.71% during 2024-2034. The hyperparathyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hyperpa...

May 2024 132 pages

Hyperpigmentation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperpigmentation markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.38...

May 2024 133 pages

Hypersomnia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypersomnia markets are expected to exhibit a CAGR of 6.68% during 2024-2034. The hypersomnia market has been comprehensively analyzed in IMARC's new report titled 'Hypersomnia Market: Epi...

May 2024 129 pages

Hypertriglyceridemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypertriglyceridemia markets are expected to exhibit a CAGR of 3.52% during 2024-2034. The hypertriglyceridemia market has been comprehensively analyzed in IMARC's new report titled 'Hyper...

May 2024 137 pages

Hypertrophic Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypertrophic cardiomyopathy markets reached a value of US$ 312.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 356.7 Million by 2034, exhibiting a growth rate...

May 2024 132 pages

Hypertrophic Scar Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypertrophic scar markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.51...

May 2024 140 pages

Hyperuricemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hyperuricemia markets are expected to exhibit a CAGR of 8.93% during 2024-2034. The hyperuricemia market has been comprehensively analyzed in IMARC's new report titled 'Hyperuricemia Marke...

May 2024 140 pages

Hypogonadism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypogonadism markets reached a value of US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.43% dur...

May 2024 133 pages

Hypoparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypoparathyroidism markets are expected to exhibit a CAGR of 7.72% during 2024-2034. The hypoparathyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hypoparat...

May 2024 136 pages

Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypophosphatasia markets reached a value of US$ 725.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,036.4 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Hypoplastic Left Heart Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypoplastic left heart syndrome markets are expected to exhibit a CAGR of 8.4% during 2024-2034. The hypoplastic left heart syndrome market has been comprehensively analyzed in IMARC's new...

May 2024 136 pages

Hypothyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypothyroidism markets are expected to exhibit a CAGR of 3.23% during 2024-2034. The hypothyroidism market has been comprehensively analyzed in IMARC's new report titled 'Hypothyroidism Ma...

May 2024 137 pages

Hypoxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major hypoxia markets are expected to exhibit a CAGR of 2.57% during 2024-2034. The hypoxia market has been comprehensively analyzed in IMARC's new report titled 'Hypoxia Market: Epidemiology, I...

May 2024 135 pages

Ichthyosiform Erythroderma/Congenital Ichthyosiform Erythroderma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major ichthyosiform erythroderma/congenital ichthyosiform erythroderma markets are expected to exhibit a CAGR of 4.35% during 2024-2034. The ichthyosiform erythroderma/congenital ichthyosiform e...

May 2024 129 pages

Ichthyosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major ichthyosis markets are expected to exhibit a CAGR of 4.12% during 2024-2034. The ichthyosis market has been comprehensively analyzed in IMARC's new report titled 'Ichthyosis Market: Epidem...

May 2024 139 pages

Idiopathic Intracranial Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major idiopathic intracranial hypertension markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The idiopathic intracranial hypertension (IIH) market has been comprehensively analyz...

May 2024 128 pages

Idiopathic Thrombocytopenic Purpura Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major idiopathic thrombocytopenic purpura markets are expected to exhibit a CAGR of 4.15% during 2024-2034. The idiopathic thrombocytopenic purpura market has been comprehensively analyzed in IM...

May 2024 137 pages

IgA Nephropathy (IgAN) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

 US$ 6,499.00

The 7 major IgA nephropathy (IgAN) markets reached a value of US$ 111.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 469.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 133 pages

Filters

Clear all

Search

Categories

18
13
12
10
9
8
8
7
7
6
6
5
4
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
75
56
45
45
44
41
41
38
38
31
30
29
28
27
26
26
24
24
23
23
23
22
22
21
21
21
21
21
20
20
19
19
19
19
18
18
17
17
16
16
15
15
15
14
14
14
14
14
13
13
13
13
13
12
12
12
12
12
12
12
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
80
22
20
17
13
12
10
10
10
10
10
10
9
9
9
8
8
7
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
22
21
18
14
14
14
13
13
13
13
12
12
10
8
8
7
7
7
7
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
41
31
29
25
22
20
8
7
7
5
4
4
4
3
3
2
2
1
1
1
1
49
34
33
16
7
5
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
23
13
13
9
7
7
7
6
4
3
3
2
1
1
1
6
4
4
3
2
1
32
9
25
1
1,751
55
26
30
213
64
26
25
15
13
1
3
150
141
158
9
252
191
27
21
7
40
6
2
2
21
401
162
15
232
19
261
225
18
7
45
25
17
16
12

Publishers

11,648

Regions

1
1
123
22
14
11
7
5
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
8
3
2
1
6
3
3
2
1
1
13
11,187
5
9
19
11
2
141
13

Price

—

Date

—

Pages

—

Offers